Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study
Yung, W. K. A., Vredenburgh, J. J., Cloughesy, T. F., Nghiemphu, P., Klencke, B., Gilbert, M. R., Reardon, D. A., Prados, M. D.Volume:
12
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/noq072
Date:
October, 2010
File:
PDF, 168 KB
english, 2010